Comorbidity of intellectual disability confounds ascertainment of autism: Implications for genetic diagnosis

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 168, Issue 7, 2015, Pages 600-608

  Polyak, Andrew ^a   Kubina, Richard M ^a   Girirajan, Santhosh ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Microdeletion; Neurodevelopmental disorders; Prevalence; Syndrome

Indexed keywords

ADOLESCENT; ADULT; AGE; AGE DISTRIBUTION; ARTICLE; AUTISM; CHILD; CLINICAL FEATURE; COMORBIDITY; COMORBIDITY ASSESSMENT; HUMAN; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SPECIAL EDUCATION; UNITED STATES; AUTISTIC DISORDER; FEMALE; GENETICS; INTELLECTUAL DISABILITY; LONGITUDINAL STUDY; MALE; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HUMANS; INTELLECTUAL DISABILITY; LONGITUDINAL STUDIES; MALE; PREVALENCE; UNITED STATES; YOUNG ADULT;

EID: 84941601049     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32338     Document Type: Article

References (62)

1. Akshoomoff N, Mattson SN, Grossfeld PD. 2015. Evidence for autism spectrum disorder in Jacobsen syndrome: Identification of a candidate gene in distal 11q. Genet Med 17(2):143-148.
2. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders (4th ed., Text Revision). Washington, DC: American Psychiatric Association.
3. Autism, Developmental Disabilities Monitoring Network Surveillance Year Principal Investigators, Centers for Disease Control and Prevention. 2014. Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill Summ 63(2):1-21.
4. Baio J, Developmental Disabilities Monitoring Network Surveillance Year Principal I, Centers for Disease C, Prevention. 2014. Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 63(2):1-21.
5. Bertrand J, Mars A, Boyle C, Bove F, Yeargin-Allsopp M, Decoufle P. 2001. Prevalence of autism in a United States population: The brick township, New Jersey, investigation. Pediatrics 108(5):1155-1161.
6. Boyle CA, Boulet S, Schieve LA, Cohen RA, Blumberg SJ, Yeargin-Allsopp M, Visser S, Kogan MD. 2011. Trends in the prevalence of developmental disabilities in US children, 1997-2008. Pediatrics 127(6):1034-1042.
7. Bruining H, Swaab H, Kas M, van Engeland H. 2009. Psychiatric characteristics in a self-selected sample of boys with Klinefelter syndrome. Pediatrics 123(5): e865-e870.
8. Casas KA, Mononen TK, Mikail CN, Hassed SJ, Li S, Mulvihill JJ, Lin HJ, Falk RE. 2004. Chromosome 2q terminal deletion: report of 6 new patients and review of phenotype-breakpoint correlations in 66 individuals. Am J Med Genet PartA 130A(4):331-339.
9. Coe BP, Girirajan S, Eichler EE. 2012. A genetic model for neurodevelopmental disease. Curr Opin Neurobiol 22(5):829-836.
10. Cristino AS, Williams SM, Hawi Z, An JY, Bellgrove MA, Schwartz CE, Costa LD, Claudianos C. 2014. Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. Mol Psychiatry 19(3):294-301.
11. Davidovitch M, Hemo B, Manning-Courtney P, Fombonne E. 2013. Prevalence and incidence of autism spectrum disorder in an Israeli population. J Autism Dev Disord 43(4):785-793.
12. Fisch GS, Davis R, Youngblom J, Gregg J. 2011. Genotype-phenotype association studies of chromosome 8p inverted duplication deletion syndrome. Behav Genet 41(3):373-380.
13. Fisch GS, Grossfeld P, Falk R, Battaglia A, Youngblom J, Simensen R. 2010. Cognitive-behavioral features of Wolf-Hirschhorn syndrome and other subtelomeric microdeletions. Am J Med Genet Part C 154C(4):417-426.
14. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, Georgieva L, Rees E, Palta P, Ruderfer DM, Carrera N, Humphreys I, Johnson JS, Roussos P, Barker DD, Banks E, Milanova V, Grant SG, Hannon E, Rose SA, Chambert K, Mahajan M, Scolnick EM, Moran JL, Kirov G, Palotie A, McCarroll SA, Holmans P, Sklar P, Owen MJ, Purcell SM, O'Donovan MC. 2014. De novo mutations in schizophrenia implicate synaptic networks. Nature 506(7487):179-184.
15. Gadow KD. 2012. Schizophrenia spectrum and attention-deficit/hyperactivity disorder symptoms in autism spectrum disorder and controls. J Am Acad Child Adolesc Psychiatry 51(10):1076-1084.
16. Garcia-Nonell C, Ratera ER, Harris S, Hessl D, Ono MY, Tartaglia N, Marvin E, Tassone F, Hagerman RJ. 2008. Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder. Am J Med Genet Part A 146A(15):1911-1916.
17. Hartshorne TS, Grialou TL, Parker KR. 2005. Autistic-like behavior in CHARGE syndrome. Am J Med Genet Part A 133A(3):257-261.
18. Howlin P, Karpf J, Turk J. 2005. Behavioural characteristics and autistic features in individuals with Cohen Syndrome. Eur Child Adolesc Psychiatry 14(2):57-64.
19. Johansson M, Wentz E, Fernell E, Stromland K, Miller MT, Gillberg C. 2001. Autistic spectrum disorders in Mobius sequence: A comprehensive study of 25 individuals. Dev Med Child Neurol 43(5):338-345.
20. Kendler KS. 2010. Advances in our understanding of genetic risk factors for autism spectrum disorders. Am J Psychiatry 167(11):1291-1293.
21. Kent L, Bowdin S, Kirby GA, Cooper WN, Maher ER. 2008. Beckwith Weidemann syndrome: A behavioral phenotype-genotype study. Am J Med Genet Part B 147B(7):1295-1297.
22. Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, Cheon KA, Kim SJ, Kim YK, Lee H, Song DH, Grinker RR. 2011. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry 168(9):904-912.
23. King BH, Lord C. 2011. Is schizophrenia on the autism spectrum? Brain Res 1380:34-41.
24. King M, Bearman P. 2009. Diagnostic change and the increased prevalence of autism. Int J Epidemiol 38(5):1224-1234.
25. Klein-Tasman BP, Phillips KD, Lord C, Mervis CB, Gallo FJ. 2009. Overlap with the autism spectrum in young children with Williams syndrome. J Dev Behav Pediatr 30(4):289-299.
26. Kogan MD, Blumberg SJ, Schieve LA, Boyle CA, Perrin JM, Ghandour RM, Singh GK, Strickland BB, Trevathan E, van Dyck PC. 2009. Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics 124(5):1395-1403.
27. Lai MC, Lombardo MV, Baron-Cohen S. 2014. Autism. Lancet 383(9920):896-910.
28. Laje G, Morse R, Richter W, Ball J, Pao M, Smith AC. 2010. Autism spectrum features in Smith-Magenis syndrome. Am J Med Genet Part C 154C(4):456-462.
29. Lerma-Carrillo I, Molina JD, Cuevas-Duran T, Julve-Correcher C, Espejo-Saavedra JM, Andrade-Rosa C, Lopez-Munoz F. 2006. Psychopathology in the Lujan-Fryns syndrome: report of two patients and review. Am J Med Genet Part A 140(24):2807-2811.
30. Levy SE, Mandell DS, Schultz RT. 2009. Autism. Lancet 374(9701):1627-1638.
31. Lichtenstein P, Carlstrom E, Rastam M, Gillberg C, Anckarsater H. 2010. The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry 167(11):1357-1363.
32. Lo ST, Siemensma E, Collin P, Hokken-Koelega A. 2013. Impaired theory of mind and symptoms of Autism Spectrum Disorder in children with Prader-Willi syndrome. Res Dev Disabil 34(9):2764-2773.
33. Lord C, Petkova E, Hus V, Gan W, Lu F, Martin DM, Ousley O, Guy L, Bernier R, Gerdts J, Algermissen M, Whitaker A, Sutcliffe JS, Warren Z, Klin A, Saulnier C, Hanson E, Hundley R, Piggot J, Fombonne E, Steiman M, Miles J, Kanne SM, Goin-Kochel RP, Peters SU, Cook EH, Guter S, Tjernagel J, Green-Snyder LA, Bishop S, Esler A, Gotham K, Luyster R, Miller F, Olson J, Richler J, Risi S. 2012. A multisite study of the clinical diagnosis of different autism spectrum disorders. Arch Gen Psychiatry 69(3):306-313.
34. Maenner MJ, Durkin MS. 2010. Trends in the prevalence of autism on the basis of special education data. Pediatrics 126(5):e1018-1025.
35. Maenner MJ, Rice CE, Arneson CL, Cunniff C, Schieve LA, Carpenter LA, Van Naarden Braun K, Kirby RS, Bakian AV, Durkin MS. 2014. Potential impact of DSM-5 criteria on autism spectrum disorder prevalence estimates. JAMA psychiatry 71(3):292-300.
36. Mitchell KJ. 2011. The genetics of neurodevelopmental disease. Curr Opin Neurobiol 21(1):197-203.
37. Moss J, Richards C, Nelson L, Oliver C. 2013. Prevalence of autism spectrum disorder symptomatology and related behavioural characteristics in individuals with Down syndrome. Autism 17(4):390-404.
38. Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C. 2009. Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res Dev Disabil 30(4):763-773.
39. Noh HJ, Ponting CP, Boulding HC, Meader S, Betancur C, Buxbaum JD, Pinto D, Marshall CR, Lionel AC, Scherer SW, Webber C. 2013. Network topologies and convergent aetiologies arising from deletions and duplications observed in individuals with autism. PLoS Genet 9(6):e1003523.
40. Peters SU, Beaudet AL, Madduri N, Bacino CA. 2004. Autism in Angelman syndrome: Implications for autism research. Clin Genet 66(6):530-536.
41. Pettersson E, Anckarsater H, Gillberg C, Lichtenstein P. 2013. Different neurodevelopmental symptoms have a common genetic etiology. J Child Psychol Psychiatry 54(12):1356-1365.
42. Phelan MC, Rogers RC, Saul RA, Stapleton GA, Sweet K, McDermid H, Shaw SR, Claytor J, Willis J, Kelly DP. 2001. 22q13 deletion syndrome. Am J Med Genet 101(2):91-99.
43. Prior M. 2003. Is there an increase in the prevalence of autism spectrum disorders? J Paediatr Child Health 39(2):81-82.
44. Rapoport J, Chavez A, Greenstein D, Addington A, Gogtay N. 2009. Autism spectrum disorders and childhood-onset schizophrenia: Clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry 48(1):10-18.
45. Rice CE, Autism Developmental Disabilities Monitoring Network Surveillance Year Principal I, Centers for Disease C, Prevention. 2007. Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill Summ 56(1):12-28.
46. Rzhetsky A, Bagley SC, Wang K, Lyttle CS, Cook EH, Jr. Altman RB, Gibbons RD. 2014. Environmental and state-level regulatory factors affect the incidence of autism and intellectual disability. PLoS Comput Biol 10(3):e1003518.
47. Shattuck PT. 2006. The contribution of diagnostic substitution to the growing administrative prevalence of autism in US special education. Pediatrics 117(4):1028-1037.
48. Sikora DM, Pettit-Kekel K, Penfield J, Merkens LS, Steiner RD. 2006. The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. Am J Med Genet Part A 140(14):1511-1518.
49. Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, Napolitano C, Schwartz PJ, Joseph RM, Condouris K, Tager-Flusberg H, Priori SG, Sanguinetti MC, Keating MT. 2004. Ca(V) 1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119(1):19-31.
50. Sporn AL, Addington AM, Gogtay N, Ordonez AE, Gornick M, Clasen L, Greenstein D, Tossell JW, Gochman P, Lenane M, Sharp WS, Straub RE, Rapoport JL. 2004. Pervasive developmental disorder and childhood-onset schizophrenia: Comorbid disorder or a phenotypic variant of a very early onset illness? Biol Psychiatry 55(10):989-994.
51. Srivastava S, Landy-Schmitt C, Clark B, Kline AD, Specht M, Grados MA. 2014. Autism traits in children and adolescents with Cornelia de Lange syndrome. Am J Med Genet Part A 164A(6):1400-1410.
52. Steinberg J, Webber C. 2013. The roles of FMRP-regulated genes in autism spectrum disorder: Single- and multiple-hit genetic etiologies. Am J Hum Genet 93(5):825-839.
53. Taylor B, Jick H, Maclaughlin D. 2013. Prevalence and incidence rates of autism in the UK: Time trend from 2004-2010 in children aged 8 years. BMJ open 3(10):e003219.
54. Taylor MJ, Charman T, Robinson EB, Hayiou-Thomas ME, Happe F, Dale PS, Ronald A. 2014. Language and traits of autism spectrum conditions: Evidence of limited phenotypic and etiological overlap. Am J Med Genet Part B 165B(7):587-595.
55. Treadwell-Deering DE, Powell MP, Potocki L. 2010. Cognitive and behavioral characterization of the Potocki-Lupski syndrome (duplication 17p11.2). J Dev Behav Pediatr 31(2):137-143.
56. Tuchman R, Rapin I. 2002. Epilepsy in autism. Lancet Neurol 1(6):352-358.
57. Varga EA, Pastore M, Prior T, Herman GE, McBride KL. 2009. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med 11(2):111-117.
58. Viscidi EW, Triche EW, Pescosolido MF, McLean RL, Joseph RM, Spence SJ, Morrow EM. 2013. Clinical characteristics of children with autism spectrum disorder and co-occurring epilepsy. PLoS ONE 8(7):e67797.
59. Wiggins LD, Baio J, Schieve L, Lee LC, Nicholas J, Rice CE. 2012. Retention of autism spectrum diagnoses by community professionals: findings from the autism and developmental disabilities monitoring network, 2000 and 2006. J Dev Behav Pediatr 33(5):387-395.
60. Williams PG, Hersh JH. 1998. Brief report: The association of neurofibromatosis type 1 and autism. J Autism Dev Disord 28(6):567-571.
61. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. 2003. Prevalence of autism in a US metropolitan area. JAMA 289(1):49-55.
62. Zafeiriou DI, Ververi A, Dafoulis V, Kalyva E, Vargiami E. 2013. Autism spectrum disorders: The quest for genetic syndromes. Am J Med Genet Part B 162B(4):327-366.